NEW YORK – Novo Nordisk A/S (NYSE: NVO), a global leader in pharmaceuticals, particularly in diabetes and obesity care, demonstrated positive momentum in early trading today. As of 10:24:07 AM EDT, the Novo Nordisk share price stood at 0.20 (+0.28%).
The market activity for NVO stock saw an opening price of $71.77, slightly above its previous close of $71.49. The day’s trading range has been between $71.26 and $72.28, indicating active investor interest. Volume for the session reached 10,116,644 shares, surpassing the average volume of 9,639,322, which suggests heightened trading activity around the pharmaceutical stock.
Novo Nordisk’s financial performance continues to be a focal point for investors. The company boasts a substantial intraday market capitalization of $307.893 billion. Key metrics include a Price-to-Earnings (P/E) ratio (TTM) of 20.23 and Earnings Per Share (EPS) (TTM) of $3.54. Investors are also noting the forward dividend and yield, which stands at $1.62, translating to a 2.26% yield. The ex-dividend date is slated for March 31, 2025.
Looking ahead, the 1-year target estimate for Novo Nordisk stock is an optimistic $91.83, significantly above its current trading price and its 52-week range of $57.00 – $148.15. This analyst outlook underscores the growth potential seen in NVO, largely driven by its innovative treatments like Ozempic and Wegovy, which have revolutionized the diabetes and weight-loss markets. The next earnings date for the company is scheduled for August 6, 2025, an event keenly watched by the investment community for further insights into Novo Nordisk’s trajectory.
With a Beta (5Y Monthly) of 0.22, NVO shares exhibit lower volatility compared to the broader market, potentially appealing to investors seeking stability alongside growth in the healthcare sector. As market open progresses, stakeholders will continue to monitor Novo Nordisk’s market update and overall stock performance.
Novo Nordisk (NVO) Stock: Frequently Asked Questions (FAQ)
Q1: What is the current stock price of Novo Nordisk (NVO)?
A: As of the latest update (10:24:07 AM EDT), the Novo Nordisk (NVO) stock price is $71.69.
Q2: What is the stock ticker symbol for Novo Nordisk A/S?
A: The stock ticker symbol for Novo Nordisk A/S is NVO on the NYSE.
Q3: Is Novo Nordisk (NVO) stock up or down today?
A: Novo Nordisk (NVO) stock is up $0.20 (+0.28%) as of the latest update.
Q4: What is the 52-week trading range for NVO stock?
A: The 52-week range for Novo Nordisk (NVO) stock is $57.00 – $148.15.
Q5: What is the market capitalization of Novo Nordisk?
A: Novo Nordisk’s intraday market capitalization is approximately $307.893 billion.
Q6: Does Novo Nordisk (NVO) pay a dividend?
A: Yes, Novo Nordisk (NVO) offers a forward dividend of $1.62, which corresponds to a yield of 2.26%. The next ex-dividend date is March 31, 2025.
Q7: What is the 1-year target estimate for Novo Nordisk stock?
A: The 1-year target estimate for NVO stock is $91.83.
Q8: What are some key financial metrics for NVO?
A: Key financial metrics for Novo Nordisk (NVO) include a P/E Ratio (TTM) of 20.23 and an EPS (TTM) of $3.54.
Q9: When is Novo Nordisk’s next earnings date?
A: Novo Nordisk’s next scheduled earnings date is August 6, 2025.
Q10: What sector does Novo Nordisk operate in?
A: Novo Nordisk is a leading company in the pharmaceutical and healthcare sectors, specializing in treatments for diabetes, obesity, and other chronic diseases.
Q11: What was the trading volume for NVO stock today?
A: The volume for NVO stock was 10,116,644 shares, which is above its average volume of 9,639,322.
